Waterloo Capital, L.P. Bristol Myers Squibb CO Transaction History
Waterloo Capital, L.P.
- $1.34 Trillion
- Q3 2025
A detailed history of Waterloo Capital, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Waterloo Capital, L.P. holds 9,106 shares of BMY stock, worth $426,251. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,106
Previous 19,702
53.78%
Holding current value
$426,251
Previous $912 Million
54.97%
% of portfolio
0.03%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...